President Donald Trump announced Thursday that brand-name pharmaceutical products will face 100% tariffs beginning October 1 unless drugmakers are actively building manufacturing plants in the United States. The policy represents a significant shift from his first term when pharmaceutical imports avoided such trade penalties. Trump defines construction requirements for tariff exemptions The president clarified through […] The post Trump targets drug companies with 100% tariff threat appeared first on Rolling Out.